Cover Image

Response‐adapted zanubrutinib and tislelizumab as a potential strategy to enhance CD19 CAR T‐cell therapy in relapsed/refractory large B‐cell lymphoma: A retrospective observational study

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Rong Shen, Wei‐Guo Cao, Li Wang, Ling‐Shuang Sheng, Yi‐Lun Zhang, Wen Wu, Peng‐Peng Xu, Shu Cheng, Meng‐Ke Liu, Yan Dong, Yue Wang, Xiang‐Qin Weng, Xu‐Feng Jiang, Qi Song, Hong‐Mei Yi, Lei Li, Sheng Chen, Zi‐Xun Yan, Wei‐Li Zhao
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Clinical and Translational Medicine
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Population pharmacokinetics and CD20 binding dynamics for mosunetuzumab in relapsed/refractory B‐cell non‐Hodgkin lymphoma
by: Brendan Bender, et al.
Published: (2024)

CAR‐DC combined with CAR‐T therapy for relapsed/refractory acute myeloid leukaemia: Research progress and future perspectives
by: Rui Zhang, et al.
Published: (2025)

Mutations of epigenetic genes and correlation with treatment response in peripheral T‐cell lymphoma
by: Chong Wei, et al.
Published: (2024)

Single‐cell analysis reveals cytotoxic and memory CD8 + T cells associated with prolonged survival in relapsed/refractory leukaemia patients after haplo+cord haematopoietic stem cell transplantation
by: Hua Li, et al.
Published: (2026)

Granulocyte colony‐stimulating factor induced T‐cell hyporesponsiveness via modulation of CD177 + S100A hi neutrophils in unexplained recurrent pregnancy loss
by: Ping‐Fen Li, et al.
Published: (2025)

Single‐cell transcriptomics reveal circulating skin‐homing CLA + CTSW + cytotoxic CD4 + T cells contribute to relapse of psoriasis
by: Hsien‐Yi Chiu, et al.
Published: (2025)

Efficacy and side effects of anti‐CD19 CAR T‐cell therapy in patients with relapsed/refractory gastrointestinal lymphoma
by: Yi Li Jiang, et al.
Published: (2024)

Neutrophil extracellular traps promote growth of lung adenocarcinoma by mediating the stability of m6A‐mediated SLC2A3 mRNA‐induced ferroptosis resistance and CD8(+) T cell inhibition
by: Li Xu, et al.
Published: (2025)

Engineered endothelial cells targeting and dihydrotanshinone I loaded bacterial extracellular vesicles for atherosclerosis therapy
by: Rong‐Rong Zhu, et al.
Published: (2025)

Atg7 in CD4+ T cells improves intestinal mucosal inflammation by regulating Ets1‐mediated T cell differentiation
by: Yue‐Tao Zhou, et al.
Published: (2025)

Optimised modular anti‐FLAG CAR T cells for solid tumor therapy
by: Xiaomeng Zhang, et al.
Published: (2025)

Molecular heterogeneity of BCL2/MYC double expressor lymphoma underlies sensitivity to histone deacetylase inhibitor
by: Zi‐Yang Shi, et al.
Published: (2024)

T‐cell differentiation stage block bias confers hypermethylation and mediastinal preference in T‐cell lymphoblastic lymphoma
by: Jiali Wang, et al.
Published: (2025)

HBx hijacks the miR‐19a‐3p/BAMBI/TGF‐β1 axis to impair the anti‐tumour activity of CD4 + T cells in diffuse large B‐cell lymphoma
by: Xuecong Guo, et al.
Published: (2026)

Identification of metabolic dysregulation and biomarkers for clear cell renal cell carcinoma
by: Bin Zheng, et al.
Published: (2024)

Enhancing CAR T‐cell therapy manufacturing efficiency through semi‐automated bioprocessing
by: Jason Isaacson, et al.
Published: (2025)

EchoBack‐CAR T cells: Tuning immunity with sound
by: Longwei Liu, et al.
Published: (2025)

Integrating multi‐omics features enables non‐invasive early diagnosis and treatment response prediction of diffuse large B‐cell lymphoma
by: Weilong Zhang, et al.
Published: (2025)

Characteristics of PD‐1+CD4+ T cells in peripheral blood and synovium of rheumatoid arthritis patients
by: Yan‐juan Chen, et al.
Published: (2024)

A nontandem novel compound chimeric antigen receptor redirected to target CD20‐CD19 positive B‐cell acute leukemias and B‐cell lymphoma
by: Vincent M DeStefano, et al.
Published: (2024)

Clinical dose rationale of tislelizumab in patients with solid or hematological advanced tumors
by: Tian Yu, et al.
Published: (2024)

The CD147 expression in CD4+ T cells is a novel biomarker for predicting efficacy of IL‐17A inhibitor and psoriasis recurrence
by: Panpan Liu, et al.
Published: (2024)

High‐dimensional spectral cytometry identifies follicular regulatory CD8 + T cells in diffuse large B‐cell lymphoma
by: Alba Díaz Herrero, et al.
Published: (2025)

Organoid‐based two‐step drug screening for rapid identification of chemotherapy‐resistant oesophageal squamous cell carcinoma and alternative therapies
by: Chen‐Ye Shao, et al.
Published: (2025)

First‐in‐human study of JNJ‐67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome
by: Rupa Narayan, et al.
Published: (2024)

Cancer stem cells: Bridging microenvironmental interactions and clinical therapy
by: Huiling Wang, et al.
Published: (2025)

Translational PK–PD model for in vivo CAR‐T‐cell therapy delivered using CAR mRNA‐loaded polymeric nanoparticle vector
by: Se Jin Kim, et al.
Published: (2024)

Harnessing CD8+ T cell dynamics in hepatitis B virus‐associated liver diseases: Insights, therapies and future directions
by: Bing Yue, et al.
Published: (2024)

Mesenchymal stem cell therapy for ulcerative colitis: Opportunities and challenges in precision medicine
by: Peng‐Fei Wang, et al.
Published: (2025)

A preclinical study of allogeneic CD19 chimeric antigen receptor double‐negative T cells as an off‐the‐shelf immunotherapy drug against B‐cell malignancies
by: Dan Wang, et al.
Published: (2024)

CD70: An emerging target for integrated cancer diagnosis and therapy
by: Jiatao Hu, et al.
Published: (2025)

Unlocking the potential of T‐cell metabolism reprogramming: Advancing single‐cell approaches for precision immunotherapy in tumour immunity
by: Lihaoyun Huang, et al.
Published: (2024)

Single‐cell RNA sequencing in exploring the pathogenesis of diabetic retinopathy
by: Xinzi Zhang, et al.
Published: (2024)

Human umbilical cord mesenchymal stem cells therapy alleviates kidney injury and podocyte apoptosis in Col4a5 knockout male mice
by: Di Lu, et al.
Published: (2025)

CD39 expression defines exhausted CD4+ T cells associated with poor survival and immune evasion in human gastric cancer
by: Zhen‐quan Duan, et al.
Published: (2024)

Sex differences in structural cell‐mediated immune regulation: Implications for precision respiratory medicine
by: Quocdai Vu, et al.
Published: (2026)

Single‐cell and spatial transcriptomics uncover neoadjuvant chemotherapy‐resistant malignant cells with inhibitory signalling on B cells in gastric cancer
by: Pei‐Yi Han, et al.
Published: (2026)

Targeting CD38 with monoclonal antibodies disrupts key survival pathways in paediatric Burkitt's lymphoma malignant B cells
by: Kathrin Kläsener, et al.
Published: (2024)

CD248 deficiency promotes angiotensin II‐induced aortic lesion by attenuating receptor stability in smooth muscle cells
by: Tai‐Tzu Hsieh, et al.
Published: (2025)

Metabolic alterations of peripheral blood immune cells and heterogeneity of neutrophil in intracranial aneurysms patients
by: Xiaolong Ya, et al.
Published: (2024)